Latest Developments in Global Embolization Particle Market

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Latest Developments in Global Embolization Particle Market

  • Medical Devices
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In May 2023, Merit Medical Systems, Inc. acquired the BioSentry® Biopsy Tract Sealant System and several dialysis catheter devices from AngioDynamics, Inc. for $100 million in cash. Additionally, Merit Medical made a $32.5 million cash payment to Bluegrass Vascular Technologies, Inc. for the Surfacer® Inside-Out® Access Catheter System. These strategic acquisitions are aimed at expanding Merit’s portfolio in the vascular and biopsy tract management sectors
  • In June 2023, Terumo Aortic launched its global Post-Approval Study (PAS), known as EXTEND, which centers on the Thoraflex Hybrid device. This device is the only Frozen Elephant Trunk (FET) device approved by the US Food and Drug Administration (FDA) for treating patients with complex aortic arch diseases. The study aims to further evaluate the device's effectiveness and long-term outcomes in this patient population
  • In December 2022, Sirtex Medical and Grand Pharmaceutical Group Limited received approval from the Chinese National Medical Products Administration for their SIR-Spheres® Y-90 resin microspheres. This milestone marked the first successful selective internal radiation therapy (SIRT) procedure using SIR-Spheres in China. The approval opens up new opportunities for the treatment of liver cancer patients in the region using this advanced therapy

Frequently Asked Questions

The market is segmented based on Segmentation, By Product Type (Radioembolization Spheres, Microspheres, Drug Eluting Beads (DEBs), PVA Particles and Gelfoam Particles, and Others), Application (Peripheral Vascular Disease, Neurology, Oncology, Urology, and Others), End User (Hospitals, Clinics, Ambulatory Centers, and Others) – Industry Trends and Forecast to 2032 .
The Global Embolization Particle Market size was valued at USD 2.40 USD Billion in 2024.
The Global Embolization Particle Market is projected to grow at a CAGR of 11.32% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..